Latest Mounjaro News and Updates : Mounjaro updates, Mounjaro News , Mounjaro around the world

Nishadil

Washington | 20°C (overcast clouds)

Rosie O'Donnell Opens Up About 60‑Pound Drop and Facelift

Top story

Rosie O'Donnell Opens Up About 60‑Pound Drop and Facelift

In focus

Latest feed

Do Weight‑Loss Drugs Really Cut Cancer Risk? A Cautious Look at the Evidence

Beyond Weight Loss: Could Ozempic and Mounjaro Actually Slow Down Aging?

The GLP-1 Dilemma: Unpacking Why Your Health Plan Isn't Covering Breakthrough Weight Loss Drugs

Navigating Love and GLP-1s: The New Era of Dating

Latest headlines

The Dating Dilemma: How and When to Talk About Your GLP-1 Medication

The Dating Dilemma: How and When to Talk About Your GLP-1 Medication

Eli Lilly’s Next‑Gen Obesity Pill Shows Promise for Sleep Apnea and More

Eli Lilly’s Next‑Gen Obesity Pill Shows Promise for Sleep Apnea and More

When Weight‑Loss Meds Meet the Restaurant Menu: Navigating the New Normal

When Weight‑Loss Meds Meet the Restaurant Menu: Navigating the New Normal

A New Chapter for Weight Loss: WW Leans into GLP-1s as Eli Lilly Explores Wider Medical Miracles

A New Chapter for Weight Loss: WW Leans into GLP-1s as Eli Lilly Explores Wider Medical Miracles

Beyond the Scale: Unpacking the 'Ozempic Personality' and Its Emotional Ripples

Beyond the Scale: Unpacking the 'Ozempic Personality' and Its Emotional Ripples

The Eli Lilly Rollercoaster: Deciphering a Volatile Week in the Market

The Eli Lilly Rollercoaster: Deciphering a Volatile Week in the Market

The Allure of Mounjaro: Navigating Your Weight Loss Journey Safely

The Allure of Mounjaro: Navigating Your Weight Loss Journey Safely

The Alarming Rise: GLP-1 Drugs Misused for Cosmetic Weight Loss in India

The Alarming Rise: GLP-1 Drugs Misused for Cosmetic Weight Loss in India

Ro Body: Is This Telehealth Weight Loss Program Your Next Step?

Ro Body: Is This Telehealth Weight Loss Program Your Next Step?

The Heart of the Matter: Do GLP-1 Medications Offer Lasting Protection, Or Is It A Momentary Truce?

The Heart of the Matter: Do GLP-1 Medications Offer Lasting Protection, Or Is It A Momentary Truce?

GLP-1 Medications: The Unveiling Truth About Sustaining Heart Health Benefits

GLP-1 Medications: The Unveiling Truth About Sustaining Heart Health Benefits

GLP-1 Medications: A Lifelong Partnership for Heart Health?

GLP-1 Medications: A Lifelong Partnership for Heart Health?

A Closer Look at GLP-1s: New Research Flags Potential Link to Sudden Sight Loss and 'Eye Stroke'

A Closer Look at GLP-1s: New Research Flags Potential Link to Sudden Sight Loss and 'Eye Stroke'

The Looming Obesity Crisis: How New Weight Loss Drugs Like Ozempic Are Changing the Game

The Looming Obesity Crisis: How New Weight Loss Drugs Like Ozempic Are Changing the Game

The Price Wars Are Coming: Ozempic & Wegovy Costs Set to Plummet

The Price Wars Are Coming: Ozempic & Wegovy Costs Set to Plummet

The Final Word: Navigating Pharma's Powerhouse and Gold's Gleam in Today's Markets

The Final Word: Navigating Pharma's Powerhouse and Gold's Gleam in Today's Markets

Why Barclays Still Sees Eli Lilly as the Undisputed Champion in the Exploding GLP-1 Arena, Even as Rivals Crowd In

Why Barclays Still Sees Eli Lilly as the Undisputed Champion in the Exploding GLP-1 Arena, Even as Rivals Crowd In

The 'Skinny Pen' Phenomenon: A Look at India's Weight Loss Drug Revolution

The 'Skinny Pen' Phenomenon: A Look at India's Weight Loss Drug Revolution

GLP-1 Medications: Separating Hype from Health with Expert Insights

GLP-1 Medications: Separating Hype from Health with Expert Insights

Eli Lilly's Ascendant Journey: Why Its Premium Price Tag Might Just Be Worth It

Eli Lilly's Ascendant Journey: Why Its Premium Price Tag Might Just Be Worth It

Novo Nordisk: The High-Stakes Balancing Act Between Price and Scale

Novo Nordisk: The High-Stakes Balancing Act Between Price and Scale

The Market's Two Minds: Lilly's High-Stakes Game Meets Housing's Quiet Comeback

The Market's Two Minds: Lilly's High-Stakes Game Meets Housing's Quiet Comeback

Eli Lilly CEO Sees Medicare Support as Game-Changer for New Oral Obesity Pill

Eli Lilly CEO Sees Medicare Support as Game-Changer for New Oral Obesity Pill

The Eli Lilly Phenomenon: Unpacking the Rocket Fuel Behind the Stock's Astounding Climb

The Eli Lilly Phenomenon: Unpacking the Rocket Fuel Behind the Stock's Astounding Climb

Unpacking GLP-1 Drugs: A Human's Guide to the Latest Metabolic Marvels

The Whole Truth About GLP-1 Drugs: Why Lasting Weight Loss Needs More Than Just a Prescription

The Whole Truth About GLP-1 Drugs: Why Lasting Weight Loss Needs More Than Just a Prescription

The Great Unbundling: Why Weight Loss Drug Prices Are Finally Coming Down

The Great Unbundling: Why Weight Loss Drug Prices Are Finally Coming Down

A Closer Look: Australia Sounds the Alarm on Popular GLP-1 Weight Loss Medications

A Closer Look: Australia Sounds the Alarm on Popular GLP-1 Weight Loss Medications

The Whole Picture: Why GLP-1 Weight Loss Drugs Aren't a Solo Act, According to WHO

The Whole Picture: Why GLP-1 Weight Loss Drugs Aren't a Solo Act, According to WHO

The Great Pharma Race: GLP-1s, Billions, and the Battle for What's Next

The Great Pharma Race: GLP-1s, Billions, and the Battle for What's Next

When Fiction Ignites Reality: How a TV Show Sent Drug Searches Soaring

When Fiction Ignites Reality: How a TV Show Sent Drug Searches Soaring

The Next Frontier: Unpacking 'Ozempic 2.0' and the Future of Weight Management

The Next Frontier: Unpacking 'Ozempic 2.0' and the Future of Weight Management

Ozempic 2.0: Is the Next-Gen Weight Loss Wonder Drug Really Here to Change Everything?

Ozempic 2.0: Is the Next-Gen Weight Loss Wonder Drug Really Here to Change Everything?

Eli Lilly's Trillion-Dollar Triumph: Reshaping the Pharma Landscape

Eli Lilly's Trillion-Dollar Triumph: Reshaping the Pharma Landscape

The Trillion-Dollar Bet: How Eli Lilly is Reshaping the Global Economy

The Trillion-Dollar Bet: How Eli Lilly is Reshaping the Global Economy

Eli Lilly's Trillion-Dollar Triumph: A New Chapter in Pharmaceutical History

Eli Lilly's Trillion-Dollar Triumph: A New Chapter in Pharmaceutical History

The Pharma Giants' Bold Leap: Novo Nordisk and Eli Lilly Eyeing Direct Sales of Obesity Drugs to Employers

The Pharma Giants' Bold Leap: Novo Nordisk and Eli Lilly Eyeing Direct Sales of Obesity Drugs to Employers

Wegovy's Reckoning: Novo Nordisk's CEO Digs In as the Weight Loss Market Heats Up

Wegovy's Reckoning: Novo Nordisk's CEO Digs In as the Weight Loss Market Heats Up

Load more